CFR makes firm offer for Adcock Ingram

18 November 2013 - Deborah Wilkes

Chile's CFR Pharmaceuticals has now made a firm offer to purchase South Africa's Adcock Ingram in a cash and share deal worth ZAR12.6 billion (US$1.30 billion). The news follows weeks of speculation about shareholder support for the proposed deal and possible competing bids.